• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2例患神经元病变型戈谢病的相关儿童的临床差异

Clinical variation in 2 related children with neuronopathic Gaucher disease.

作者信息

Grover W D, Tucker S H, Wenger D A

出版信息

Ann Neurol. 1978 Mar;3(3):281-3. doi: 10.1002/ana.410030316.

DOI:10.1002/ana.410030316
PMID:96723
Abstract

The clinical features in 2 second cousins with neuronopathic Gaucher disease include slowly progressive ataxia, spasticity, myoclonus, and seizures with relative preservation of intellectual function. Organomegaly was noted only in Patient 1. Both patients had diffuse slowing with paroxysmal features in electroencephalograms and a deficiency of beta-glucosidase activity in leukocytes and skin fibroblast cultures. The parents of Patient 1 and the related father of Patient 2 had levels of beta-glucosidase activity consistent with the carrier state for Gaucher disease. The value of beta-glucosidase activity in the mother of Patient 2 suggests a different mutation, the result being a defective enzyme component not detectable by measuring total activity.

摘要

2名患有神经病变型戈谢病的表亲的临床特征包括缓慢进展的共济失调、痉挛、肌阵挛和癫痫发作,同时智力功能相对保留。仅在患者1中发现器官肿大。两名患者脑电图均有弥漫性减慢并伴有阵发性特征,白细胞和皮肤成纤维细胞培养物中β-葡萄糖苷酶活性缺乏。患者1的父母及患者2的相关父亲的β-葡萄糖苷酶活性水平与戈谢病携带者状态一致。患者2母亲的β-葡萄糖苷酶活性值提示存在不同的突变,结果是通过测量总活性无法检测到有缺陷的酶成分。

相似文献

1
Clinical variation in 2 related children with neuronopathic Gaucher disease.2例患神经元病变型戈谢病的相关儿童的临床差异
Ann Neurol. 1978 Mar;3(3):281-3. doi: 10.1002/ana.410030316.
2
Genetic heterogeneity in Gaucher disease: physicokinetic and immunologic studies of the residual enzyme in cultured fibroblasts from non-neuronopathic and neuronopathic patients.戈谢病的遗传异质性:非神经病变型和神经病变型患者培养成纤维细胞中残余酶的物理动力学和免疫学研究。
Am J Med Genet. 1985 Jul;21(3):529-49. doi: 10.1002/ajmg.1320210316.
3
Gaucher disease among Chinese patients: review on genotype/phenotype correlation from 29 patients and identification of novel and rare alleles.中国患者中的戈谢病:29例患者基因型/表型相关性综述及新的罕见等位基因鉴定
Blood Cells Mol Dis. 2007 May-Jun;38(3):287-93. doi: 10.1016/j.bcmd.2006.11.003. Epub 2006 Dec 29.
4
The cytosolic β-glucosidase GBA3 does not influence type 1 Gaucher disease manifestation.细胞质β-葡萄糖苷酶 GBA3 不会影响 1 型戈谢病的表现。
Blood Cells Mol Dis. 2011 Jan 15;46(1):19-26. doi: 10.1016/j.bcmd.2010.07.009. Epub 2010 Aug 21.
5
Gaucher disease: accurate identification of asymptomatic French-Canadian carrier using nonlabeled authentic sphingolipid substrate N-palmitoyl dihydroglucocerebroside.戈谢病:使用未标记的天然鞘脂底物N-棕榈酰二氢葡萄糖脑苷脂准确鉴定无症状法裔加拿大携带者。
Am J Med Genet. 1987 Aug;27(4):895-905. doi: 10.1002/ajmg.1320270416.
6
Mutation analysis of 28 Gaucher disease patients: the Australasian experience.28例戈谢病患者的突变分析:澳大利亚和新西兰的经验。
Am J Med Genet. 1994 Jan 15;49(2):218-23. doi: 10.1002/ajmg.1320490212.
7
Biochemical properties of beta-glucosidase in leukocytes from patients and obligated heterozygotes for Gaucher disease carriers.戈谢病携带者患者及 obligate 杂合子白细胞中β-葡萄糖苷酶的生化特性。 (注:“obligate heterozygotes”直译为“ obligate 杂合子”,这里的“obligate”在医学遗传学中有特定含义,可能需要更多背景知识来准确理解其确切所指,比如“必然杂合子”等,具体含义需结合专业领域进一步明确,但按要求不添加解释直接翻译)
Clin Chim Acta. 2005 Dec;362(1-2):101-9. doi: 10.1016/j.cccn.2005.06.010. Epub 2005 Jul 22.
8
Clinical and enzyme studies in Gaucher disease.戈谢病的临床与酶学研究。
Indian Pediatr. 1996 Sep;33(9):735-8.
9
Non-neuronopathic Gaucher disease due to saposin C deficiency.由于鞘磷脂激活蛋白C缺乏导致的非神经元型戈谢病。
Clin Genet. 2007 Dec;72(6):538-42. doi: 10.1111/j.1399-0004.2007.00899.x. Epub 2007 Oct 7.
10
Mutations in the gene encoding cytosolic beta-glucosidase in Gaucher disease.戈谢病中编码胞质β-葡萄糖苷酶的基因突变。
J Lab Clin Med. 2004 Aug;144(2):65-8. doi: 10.1016/j.lab.2004.03.013.

引用本文的文献

1
Exploring Pro-Inflammatory Immunological Mediators: Unraveling the Mechanisms of Neuroinflammation in Lysosomal Storage Diseases.探索促炎免疫介质:揭示溶酶体贮积病中的神经炎症机制
Biomedicines. 2023 Apr 1;11(4):1067. doi: 10.3390/biomedicines11041067.
2
Targeting the Complement-Sphingolipid System in COVID-19 and Gaucher Diseases: Evidence for a New Treatment Strategy.靶向 COVID-19 和戈谢病中的补体-鞘脂系统:一种新治疗策略的证据。
Int J Mol Sci. 2022 Nov 18;23(22):14340. doi: 10.3390/ijms232214340.
3
Late-infantile Gaucher disease in a child with myoclonus and bulbar signs: neuropathological and neurochemical findings.
Acta Neuropathol. 1991;82(2):152-7. doi: 10.1007/BF00293959.